Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience


Creative Commons License

AYGEN B., DEMİRTÜRK N., YILDIZ O., ÇELEN M. K., ÇELİK İ., BARUT H. Ş., ...More

AASLD - TASL CONNECT REGIONAL MEETING, 15 - 16 March 2019, vol.30, pp.10-15

  • Publication Type: Conference Paper / Full Text
  • Volume: 30
  • Doi Number: 10.5152/tjg.2019.07
  • Page Numbers: pp.10-15
  • Erciyes University Affiliated: Yes